Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.460
-0.060 (-2.38%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -121.34 | -102.33 | -52.37 | -42.86 | -100.61 | |
| Depreciation & Amortization | 0.18 | 0.18 | 0.18 | 0.17 | 0 | |
| Asset Writedown & Restructuring Costs | - | - | 0.74 | - | - | |
| Loss (Gain) From Sale of Investments | -0.87 | -5.11 | -3.13 | 0.49 | 0.16 | |
| Stock-Based Compensation | 9.85 | 9.64 | 6.15 | 3.06 | 0.92 | |
| Other Operating Activities | 1.75 | -0.24 | 1.51 | - | 81.27 | |
| Change in Accounts Payable | -5.09 | 4.27 | -0.26 | 0.55 | 0.56 | |
| Change in Other Net Operating Assets | -0.03 | 7.38 | 4.13 | 3.43 | -0.26 | |
| Operating Cash Flow | -115.54 | -86.22 | -43.06 | -35.15 | -17.96 | |
| Capital Expenditures | -0.09 | -0.02 | -0.02 | -0.16 | -0.04 | |
| Sale of Property, Plant & Equipment | - | - | 0 | - | - | |
| Investment in Securities | 134.02 | 48.04 | -171.65 | 39.35 | -104.08 | |
| Investing Cash Flow | 133.93 | 48.03 | -171.67 | 39.19 | -104.12 | |
| Long-Term Debt Issued | - | - | 30 | - | - | |
| Long-Term Debt Repaid | - | -0.74 | - | - | - | |
| Net Debt Issued (Repaid) | - | -0.74 | 30 | - | - | |
| Issuance of Common Stock | 0.04 | 7.94 | 122.23 | 3.91 | 169.19 | |
| Repurchase of Common Stock | -0.07 | -0.04 | - | - | - | |
| Other Financing Activities | - | -0.23 | -0.48 | - | - | |
| Financing Cash Flow | -0.03 | 6.93 | 151.75 | 3.91 | 200.47 | |
| Net Cash Flow | 18.36 | -31.26 | -62.98 | 7.94 | 78.39 | |
| Free Cash Flow | -115.63 | -86.23 | -43.09 | -35.31 | -18 | |
| Free Cash Flow Per Share | -1.91 | -1.44 | -0.89 | -0.87 | -0.90 | |
| Cash Interest Paid | 2.94 | 2.97 | 0.17 | - | - | |
| Levered Free Cash Flow | -75.11 | -52.29 | -28.24 | -20.94 | -16.35 | |
| Unlevered Free Cash Flow | -72.47 | -49.75 | -27.87 | -20.94 | -16.35 | |
| Change in Working Capital | -5.12 | 11.65 | 3.87 | 3.99 | 0.3 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.